Is Lionco Pharmaceutical Group Co Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Lionco Pharmaceutical Group Co Ltd (603669.SS) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Lionco Pharmaceutical Group Co Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lionco Pharmaceutical Group Co Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Lionco Pharmaceutical Group Co Ltd?

Muslim investors may consider investing in Lionco Pharmaceutical Group Co Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lionco Pharmaceutical Group Co Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Lionco Pharmaceutical Group Co Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lionco Pharmaceutical Group Co Ltd updated?

The Shariah compliance status of Lionco Pharmaceutical Group Co Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lionco Pharmaceutical Group Co Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lionco Pharmaceutical Group Co Ltd?

You can check the latest Shariah compliance status of Lionco Pharmaceutical Group Co Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Lionco Pharmaceutical Group Co Ltd 603669.SS

Last Updated: May 15, 12:00 AM·SSE

Lionco Pharmaceutical Group Co Ltd. Stock Analysis 603669.SS

China Health Care Small Cap

Lionco Pharmaceutical Group Co., Ltd. engages in the sale of chemical drug and antibiotic agents. The company is headquartered in Shannan, Xizang. The company went IPO on 2015-05-28. The Company’s main products cover four main categories: parenteral nutrition, anti-infectives, digestive system drugs, and cardiovascular and cerebrovascular drugs. The Company’s main products include Huperzine A for Injection, Cefmetazole Sodium for Injection, Cefuroxime Sodium for Injection, Cefuroxime Sodium for Injection, Alanyl-Glutamine Injection and others. The firm mainly operates its businesses in the domestic market.

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.

I accept the above